AELIS FARMA
Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways. Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.
AELIS FARMA
Industry:
Biotechnology Therapeutics
Founded:
2013-01-01
Address:
Bordeaux, Aquitaine, France
Country:
France
Website Url:
http://www.aelisfarma.com
Total Employee:
11+
Status:
Active
Contact:
+33 5 57 57 37 70
Email Addresses:
[email protected]
Total Funding:
26 M EUR
Technology used in webpage:
Google Maps French Server Location
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Apeiron Biologics
Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.
AYOXXA
AYOXXA is a biotech company commercializing innovative technology.
Iksuda Therapeutics
Iksuda Therapeutics is a biotechnology company specializing in the development of next generation biotherapeutics
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
InventisBio
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
Nascent Biotech
Nascent Biotech is a biotechnology company building a portfolio of innovative therapeutic antibodies.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Employees Featured
Founder
Stock Details
Investors List
Bpifrance
Bpifrance investment in Venture Round - Aelis Farma
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Aelis Farma
Inserm Transfert Initiative
Inserm Transfert Initiative investment in Venture Round - Aelis Farma
Aelis Innovation
Aelis Innovation investment in Venture Round - Aelis Farma
Région Nouvelle-Aquitaine
Région Nouvelle-Aquitaine investment in Venture Round - Aelis Farma
fonds régionaux ACI
fonds régionaux ACI investment in Venture Round - Aelis Farma
NACO
NACO investment in Venture Round - Aelis Farma
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-17 | Aelis Farma Strengthens its Leadership Team with the Appointment of Arsène Guekam as Chief Corporate Development Officer |
Official Site Inspections
http://www.aelisfarma.com Semrush global rank: 10.62 M Semrush visits lastest month: 211
- Host name: cluster006.ovh.net
- IP address: 213.186.33.17
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Aelis Farma"
About Us - AelisFarma
In a mere 8 years we have developed two clinical drug candidates and built an innovative and …See details»
Aelis Farma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +33 5 57 57 37 70 Aelis Farma is a pioneer in the development of signaling specific therapeutics that …See details»
Investors - AelisFarma
[email protected]. NewCap. Financial communication & Investor relations. Dusan Oresansky / Aurélie Manavarere +33 (0)1 44 71 94 92. [email protected]. Media relations.See details»
Aelis Farma SA (EPA: AELIS) Company Profile & Overview - Stock …
6 days ago Company profile for Aelis Farma SA (EPA: AELIS) with a description, list of …See details»
AELIS FARMA - LinkedIn
Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases. Aelis Farma is developing a new class of drugs: Signaling Specific ...See details»
Aelis Farma Company Profile 2024: Stock Performance …
Information on stock, financials, earnings, subsidiaries, investors, and executives for Aelis Farma. Use the PitchBook Platform to explore the full profile.See details»
Aelis Farma - Overview, News & Similar companies - ZoomInfo
Aug 27, 2023 Who is Aelis Farma. AELIS FARMA is a clinical-stage biotechnology company …See details»
Aelis Farma - Company Profile - Tracxn
Nov 18, 2024 Aelis Farma - Developer of small molecule drugs targeting CB1 receptor for …See details»
AELIS FARMA - Company Profile & Staff Directory - ContactOut
Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of …See details»
Aelis Farma S.A. - Life-Sciences-Europe.com
Https://www.aelisfarma.com AELIS FARMA is a clinical-stage biotechnology company founded …See details»
Aelis Farma - VentureRadar
"Aelis Farma is develop the therapeutic potential of CB1-SSi(CB1 Signaling Specific inhibitors). …See details»
About Us - AelisFarma
En 8 ans seulement nous avons amené deux candidats-médicaments en clinique et bâti une …See details»
Aelis Farma - Craft
Aelis Farma is a clinical-stage biotech company that specializes in pharmacology. It aims to …See details»
Aelis Farma CEO Pier Vincenzo Piazza Receives the EY …
Oct 4, 2022 For more information: www.aelisfarma.com. About the global EY organization. …See details»
Aelis Farma, a pioneer of a new generation of drugs for the brain
Feb 15, 2022 AELIS FARMA Pier Vincenzo Piazza Co-founder and CEO …See details»
Aelis Farma Announces Its 2024 Financial Calendar - Yahoo Finance
BORDEAUX, France, January 30, 2024--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 …See details»
Home - AelisFarma
Aelis Farma is a biotechnology company specialized in the treatment of brain disordersSee details»
Aelis Farma Announces Completion of Patient ... - Business Wire
Jan 9, 2024 AELIS FARMA Pier Vincenzo Piazza CEO [email protected]. NewCap …See details»
AelisFarma
• As planned, 333 patients have been randomized at end of December 2023 across 11 clinical …See details»